|
1
|
Ottaviani G and Jaffe N: The epidemiology
of osteosarcoma. Cancer Treat Res. 152:3–13. 2009. View Article : Google Scholar
|
|
2
|
Morrow JJ and Khanna C: Osteosarcoma
genetics and epigenetics: Emerging biology and candidate therapies.
Crit Rev Oncog. 20:173–197. 2015. View Article : Google Scholar :
|
|
3
|
Admassi D: Osteosarcoma of medial cuniform
bone. Ethiop Med J. 47:305–308. 2009.
|
|
4
|
Miao J, Wu S, Peng Z, Tania M and Zhang C:
MicroRNAs in osteosarcoma: Diagnostic and therapeutic aspects.
Tumour Biol. 34:2093–2098. 2013. View Article : Google Scholar
|
|
5
|
Osborne TS and Khanna C: A review of the
association between osteosarcoma metastasis and protein
translation. J Comp Pathol. 146:132–142. 2012. View Article : Google Scholar :
|
|
6
|
Akiyama T, Dass CR and Choong PF: Novel
therapeutic strategy for osteosarcoma targeting osteoclast
differentiation, bone-resorbing activity, and apoptosis pathway.
Mol Cancer Ther. 7:3461–3469. 2008. View Article : Google Scholar
|
|
7
|
Miska EA: How microRNAs control cell
division, differentiation and death. Curr Opin Genet Dev.
15:563–568. 2005. View Article : Google Scholar
|
|
8
|
Cai Y, Yu X, Hu S and Yu J: A brief review
on the mechanisms of miRNA regulation. Genomics Proteomics
Bioinformatics. 7:147–154. 2009. View Article : Google Scholar
|
|
9
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar :
|
|
10
|
Feng B, Zhang K, Wang R and Chen L:
Non-small-cell lung cancer and miRNAs: Novel biomarkers and
promising tools for treatment. Clin Sci (Lond). 128:619–634. 2015.
View Article : Google Scholar
|
|
11
|
van Rooij E: The art of microRNA research.
Circ Res. 108:219–234. 2011. View Article : Google Scholar
|
|
12
|
Liu X, Zhang J, Xie B, Li H, Shen J and
Chen J: MicroRNA-200 family profile: A promising ancillary tool for
accurate cancer diagnosis. Am J Ther. 23:e388–e397. 2016.
View Article : Google Scholar :
|
|
13
|
Oom AL, Humphries BA and Yang C:
MicroRNAs: Novel players in cancer diagnosis and therapies. Biomed
Res Int. 2014:9594612014. View Article : Google Scholar :
|
|
14
|
He C, Xiong J, Xu X, et al: Functional
elucidation of MiR-34 in osteosarcoma cells and primary tumor
samples. Biochem Biophys Res Commun. 388:35–40. 2009. View Article : Google Scholar
|
|
15
|
Zhao H, Ma B, Wang Y, et al: miR-34a
inhibits the metastasis of osteosarcoma cells by repressing the
expression of CD44. Oncol Rep. 29:1027–1036. 2013.
|
|
16
|
Ziyan W, Shuhua Y, Xiufang W and Xiaoyun
L: MicroRNA-21 is involved in osteosarcoma cell invasion and
migration. Med Oncol. 28:1469–1474. 2011. View Article : Google Scholar
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
18
|
Yang C, Hou C, Zhang H, Wang D, Ma Y,
Zhang Y, Xu X, Bi Z and Geng S: miR-126 functions as a tumor
suppressor in osteosarcoma by targeting Sox2. Int J Mol Sci.
15:423–437. 2013. View Article : Google Scholar :
|
|
19
|
Wong N and Wang X: miRDB: An online
resource for microRNA target prediction and functional annotations.
Nucleic Acids Res. 43:D146–D152. 2015. View Article : Google Scholar
|
|
20
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar
|
|
21
|
Li J, Du L, Yang Y, Wang C, Liu H, Wang L,
Zhang X, Li W, Zheng G and Dong Z: MiR-429 is an independent
prognostic factor in colorectal cancer and exerts its
anti-apoptotic function by targeting SOX2. Cancer Lett. 329:84–90.
2013. View Article : Google Scholar
|
|
22
|
Leonardo TR, Schultheisz HL, Loring JF and
Laurent LC: The functions of microRNAs in pluripotency and
reprogramming. Nat Cell Biol. 14:1114–1121. 2012. View Article : Google Scholar
|
|
23
|
Croset M, Santini D, Iuliani M, et al:
MicroRNAs and bone metastasis: a new challenge. Molecules.
19:10115–10128. 2014. View Article : Google Scholar
|
|
24
|
Sukata T, Sumida K, Kushida M, et al:
Circulating microRNAs, possible indicators of progress of rat
hepatocarcinogenesis from early stages. Toxicol Lett. 200:46–52.
2011. View Article : Google Scholar
|
|
25
|
Truettner JS, Katyshev V, Esen-Bilgin N,
Dietrich WD and Dore-Duffy P: Hypoxia alters MicroRNA expression in
rat cortical pericytes. Microrna. 2:32–44. 2013. View Article : Google Scholar :
|
|
26
|
Basu-Roy U, Seo E, Ramanathapuram L, Rapp
TB, Perry JA, Orkin SH, Mansukhani A and Basilico C: Sox2 maintains
self renewal of tumor-initiating cells in osteosarcomas. Oncogene.
31:2270–2282. 2012. View Article : Google Scholar
|
|
27
|
Basu-Roy U, Ambrosetti D, Favaro R,
Nicolis SK, Mansukhani A and Basilico C: The transcription factor
Sox2 is required for osteoblast self-renewal. Cell Death Differ.
17:1345–1353. 2010. View Article : Google Scholar :
|
|
28
|
Mansukhani A, Ambrosetti D, Holmes G,
Cornivelli L and Basilico C: Sox2 induction by FGF and FGFR2
activating mutations inhibits Wnt signaling and osteoblast
differentiation. J Cell Biol. 168:1065–1076. 2005. View Article : Google Scholar :
|
|
29
|
Zhang Y, Yeh LK, Zhang S, Call M, Yuan Y,
Yasunaga M, Kao WW and Liu CY: Wnt/β-catenin signaling modulates
corneal epithelium stratification via inhibition of Bmp4 during
mouse development. Development. 142:3383–3393. 2015. View Article : Google Scholar :
|
|
30
|
Bass AJ, Watanabe H, Mermel CH, Yu S,
Perner S, Verhaak RG, Kim SY, Wardwell L, Tamayo P, Gat-Viks I, et
al: SOX2 is an amplified lineage-survival oncogene in lung and
esophageal squamous cell carcinomas. Nat Genet. 41:1238–1242. 2009.
View Article : Google Scholar :
|
|
31
|
Sun C, Sun L, Li Y, Kang X, Zhang S and
Liu Y: Sox2 expression predicts poor survival of hepatocellular
carcinoma patients and it promotes liver cancer cell invasion by
activating Slug. Med Oncol. 30:5032013. View Article : Google Scholar
|
|
32
|
Deng Z, Du WW, Fang L, Shan SW, Qian J,
Lin J, Qian W, Ma J, Rutnam ZJ and Yang BB: The intermediate
filament vimentin mediates microRNA miR-378 function in cellular
self-renewal by regulating the expression of the Sox2 transcription
factor. J Biol Chem. 288:319–331. 2013. View Article : Google Scholar
|
|
33
|
Zhang Y, Eades G, Yao Y, Li Q and Zhou Q:
Estrogen receptor α signaling regulates breast tumor-initiating
cells by down-regulating miR-140 which targets the transcription
factor SOX2. J Biol Chem. 287:41514–41522. 2012. View Article : Google Scholar :
|
